GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Read-Gene SA (WAR:RDG) » Definitions » Market Cap

Read-Gene (WAR:RDG) Market Cap : zł56.00 Mil (As of Dec. 11, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Read-Gene Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Read-Gene's share price for the quarter that ended in Sep. 2024 was zł5.82. Read-Gene's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 11.79 Mil. Therefore, Read-Gene's market cap for the quarter that ended in Sep. 2024 was zł68.62 Mil.

Read-Gene's quarterly market cap declined from Mar. 2024 (zł62.49 Mil) to Jun. 2024 (zł58.71 Mil) but then increased from Jun. 2024 (zł58.71 Mil) to Sep. 2024 (zł68.62 Mil).

Read-Gene's annual market cap declined from Dec. 2021 (zł33.13 Mil) to Dec. 2022 (zł30.42 Mil) but then increased from Dec. 2022 (zł30.42 Mil) to Dec. 2023 (zł68.38 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Read-Gene's Enterprise Value for Today is zł57.87 Mil.


Read-Gene Market Cap Historical Data

The historical data trend for Read-Gene's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Read-Gene Market Cap Chart

Read-Gene Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.78 30.65 33.13 30.42 68.38

Read-Gene Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36.55 68.38 62.49 58.71 68.62

Competitive Comparison of Read-Gene's Market Cap

For the Biotechnology subindustry, Read-Gene's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Read-Gene's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Read-Gene's Market Cap distribution charts can be found below:

* The bar in red indicates where Read-Gene's Market Cap falls into.



Read-Gene Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Read-Gene's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=zł5.8*11.79
=zł68.38

Read-Gene's Market Cap for the quarter that ended in Sep. 2024 is calculated as

Market Cap (Q: Sep. 2024 )=Share Price (Q: Sep. 2024 )*Shares Outstanding (EOP) (Q: Sep. 2024 )
=zł5.82*11.79
=zł68.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Read-Gene  (WAR:RDG) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Read-Gene Market Cap Related Terms

Thank you for viewing the detailed overview of Read-Gene's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Read-Gene Business Description

Traded in Other Exchanges
N/A
Address
Ulica Alabastrowa 8, Grzepnica, Dobra, POL, 72-003
Read-Gene SA treats each patient individually based on genetic tests. The company's segments include chemoprevention, clinical trials and genetic tests. It also engaged in developing technologies to commercialize methods to detect, prevent and treat malignant tumours.

Read-Gene Headlines

No Headlines